<DOC>
	<DOC>NCT00399633</DOC>
	<brief_summary>The study aim at examining whether Sumatriptan changes the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.</brief_summary>
	<brief_title>Neuropeptides in the Humane Intra- og Extracerebral Circulation.</brief_title>
	<detailed_description>The study is meant to give a better understanding of the basic mechanisms behind migraine, and a better understanding of the effects of sumatriptan on the trigemino vascular system. The endpoints are changes in the plasma values of the neuropeptides vasoactive intestinal polypeptide (VIP), calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) and the prostanoids 6-keto-PGF1α, and PGE2, PGD2 og PGF2α.</detailed_description>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>healthy volunteers 1850 years, 50100 kg. Fertile women must use birth control. All primary types of headache Daily intake of medicine except birth control Pregnancy Hypertension Hypotension other chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>VIP</keyword>
	<keyword>PACAP</keyword>
	<keyword>CGRP</keyword>
	<keyword>Prostanoids</keyword>
</DOC>